Systemic lupus erythematosus, unspecified
Description
systemic lupus erythematosus: An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.
Data source
| FinnGen phenocode | SLE_NOS |
| Hospital Discharge registry | ICD-10: M329 |
| Cause of Death registry | ICD-10: M329 |
| First defined in version | DF2 |
Key figures
| Sex | All | Female | Male |
| Number of individuals | 244 | 209 | 35 |
| Unadjusted prevalence (%) | 0.18 | 0.28 | 0.06 |
| Mean age at first event (years) | 50.02 | 49.68 | 52.06 |
| Median number of events / individual | 6 | 6 | 4 |
Clinical metrics
| Sex | All | Female | Male |
| Recurrence within 6 months (%) | 68.44 | 67.94 | 71.43 |
| Case fatality at 5-years (%) | 4.1 | 4.78 | 0.0 |